Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of
nitazoxanide-peginterferon and nitazoxanide-peginterferon-ribavirin combination regimens
compared to the standard of care (peginterferon-ribavirin) in treating chronic hepatitis C
genotype 4. The study will also evaluate the effect of the studied treatment regimens on end
of treatment virologic response, ALT normalization and safety parameters.